Creative Medical Technology Holdings (CELZ) Inventory (2020 - 2026)
Creative Medical Technology Holdings' (CELZ) quarterly Inventory came in at $125000.0 in Q2 2026, up 12475.45% year-over-year from N/an in Q2 2025, and little changed quarter-over-quarter from $125000.0 in Q1 2026.
Analysis
Creative Medical Technology Holdings (CELZ) Inventory (2020 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Inventory for 7 consecutive years, with $125000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Inventory rose 12475.45% year-over-year to $125000.0 in Q2 2026; TTM through Jun 2026 was $125000.0, a 12475.45% increase from a year earlier, with the FY2024 full-year figure at $2194.0, down 66.73% from the prior year.
- Inventory was $125000.0 for Q2 2026 at Creative Medical Technology Holdings, roughly flat from $125000.0 in the prior quarter.
- Over five years, Inventory peaked at $125000.0 in Q1 2026 and troughed at $994.0 in Q1 2025.
- A 5-year average of $21423.4 and a median of $7794.0 in 2023 frame the typical range for Inventory.
- Across the five-year window, Inventory tumbled 84.93% in 2025 and soared 12475.45% in 2026, its largest moves.
- Over 5 years, Inventory stood at $10194.0 in 2022, then tumbled by 35.31% to $6594.0 in 2023, then slumped by 66.73% to $2194.0 in 2024, then slumped by 54.69% to $994.0 in 2025, then soared by 12475.45% to $125000.0 in 2026.
- The last three Inventory figures came in at $125000.0 (Q2 2026), $125000.0 (Q1 2026), and $994.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 45.56 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 55.59 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 41.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 20.25 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 904.27 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 18.38 Mn |
| 10 | Creative Medical Technology Holdings | 1.48 Mn | 1.50 Mn | - | 125,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125,000.00 |
| Mar 31, 2026 | 125,000.00 |
| Sep 30, 2025 | 994.00 |
| Jun 30, 2025 | 994.00 |
| Mar 31, 2025 | 994.00 |
| Dec 31, 2024 | 2,194.00 |
| Sep 30, 2024 | 3,394.00 |
| Jun 30, 2024 | 3,394.00 |
| Mar 31, 2024 | 6,594.00 |
| Dec 31, 2023 | 6,594.00 |
| Sep 30, 2023 | 7,794.00 |
| Jun 30, 2023 | 10,194.00 |
| Mar 31, 2023 | 10,194.00 |
| Dec 31, 2022 | 10,194.00 |
| Sep 30, 2022 | 15,894.00 |
| Jun 30, 2022 | 20,625.00 |
| Mar 31, 2022 | 14,150.00 |
| Dec 31, 2021 | 10,866.00 |
| Jun 30, 2020 | 1,200.00 |
| Mar 31, 2020 | 2,800.00 |